PHEN Summit

by Covid-19

Session I: September 7, 2022

Understanding and Addressing the Impact of COVID-19 on the Prostate Cancer Racial Disparity

During the COVID-19 pandemic prostate cancer early detection screenings and treatments were delayed. This session will examine how Black patients were impacted compared to other patients. It will also examine the challenges faced today in catching up while handling the dramatic increase in the number of new prostate cancer cases estimated by the American Cancer Society (ACS). The ACS estimated a 30% increase in new prostate cancer cases in 2021 and an additional 8% increase for 2022 for 268,490 new cases in 2022 alone. This is the largest increase of new cases for any of the four major cancers.

The session presenters were joined on the panel by other leaders to discuss the impact of the COVID-19 pandemic on the prostate cancer racial disparity, and the challenges to move progress forward towards eliminating the disparity.

Your opinion matters.

 

Thaddeus J. Bell, MD
  • Facebook
  • Twitter
  • LinkedIn

Thaddeus J. Bell, MD

Founder

I am Dr. Thaddeus John Bell, closing the gap in health disparities for African Americans and the underserved.